BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  Viracor Eurofins Collaborates with Northwestern University Comprehensive Transplant Center on Specialized Kidney Transplant Diagnostic

  Viracor Eurofins, a leader in transplant testing, announced its research collaboration with the Northwestern University Comprehensive Transplant Center, a leader in solid organ transplantation medicine in North America through high impact research and its clinical training programs.

  August 21, 2019

   · 

  5 min read
• Business

  Shield Diagnostics Appoints David Esposito to its Board of Directors

  Shield Diagnostics, an Andreessen Horowitz-backed biotechnology company tackling antibiotic resistance by bringing precision medicine to infectious disease, announced today that it has appointed David Esposito to its Board of Directors.

  August 21, 2019

   · 

  2 min read
• Deals

  Hansa Biopharma to Participate in Three Upcoming Investor Conferences

  Hansa Biopharma has been invited to participate in three global biotech and healthcare conferences during September including Goldman Sachs’ Biotech Symposium in London, Morgan Stanley’s Global Healthcare conference in New York City and Bank of America Merrill Lynch Global Healthcare Conference in London

  August 21, 2019

   · 

  1 min read
• Drug Development

  BioInvent Will Conduct Phase l/lla Trial With BI-1206 in Combination With Pembrolizumab (Keytruda) in Solid Tumors

  BioInvent International AB announced that the earlier communicated phase l/lla clinical trial in solid cancer will be conducted with BI-1206, one of BioInvent’s proprietary anti-FcγRllB antibodies, in combination with pembrolizumab, a leading anti-PD1 antibody.

  August 21, 2019

   · 

  3 min read
• Policy

  Largest Physician Quality Improvement Initiative in California History Yields Huge Health Benefit for Patients, $345 Million in Savings

  9,800 California providers work together to improve health for 5.9 million Californians, saving $6 for every $1 invested

  August 21, 2019

   · 

  5 min read
• Deals

  Global Cord Blood Corporation to Report First Quarter Fiscal 2020 Financial Results

  Global Cord Blood Corporation announced that it plans to release financial results for the first quarter fiscal 2020 on Tuesday, August 27, 2019, after the market close.

  August 21, 2019

   · 

  2 min read
• Deals

  Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors

  Oncorus, Inc. announced the completion of an oversubscribed $79.5 million Series B financing.

  August 21, 2019

   · 

  5 min read
• Biotech Bay

  Early Access Care Selects Veeva Vault CDMS for Expanded Access Study

  Veeva Vault CDMS to manage clinical data for expanded access program for a neurologic disorder treatment

  August 21, 2019

   · 

  2 min read
• Drug Development

  Aimmune Enrolls First Patient in Phase 2 Trial of AR201 for Egg Allergy

  Aimmune Therapeutics, Inc. announced that it has randomized its first patient in a phase 2 clinical trial of AR201 for the treatment of egg allergy.

  August 21, 2019

   · 

  7 min read
• Policy

  Third Pole Therapeutics Issued New U.S. Patents

  Newest Patents Cover Nitric Oxide Generation and Wearable Delivery Systems

  August 21, 2019

   · 

  2 min read